Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
156.35B
Market cap156.35B
Price-Earnings ratio
39.39
Price-Earnings ratio39.39
Dividend yield
6.25%
Dividend yield6.25%
Average volume
34.23M
Average volume34.23M
High today
$28.11
High today$28.11
Low today
$27.36
Low today$27.36
Open price
$27.80
Open price$27.80
Volume
38.32M
Volume38.32M
52 Week high
$31.44
52 Week high$31.44
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $27.44. The company's market cap stands at 156.35B, with a P/E ratio of 39.39 and a dividend yield of 6.25%.

On 2026-11-20, Pfizer(PFE) stock moved within a range of $27.36 to $28.11. With shares now at $27.44, the stock is trading +0.3% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 38.32M, compared to an average daily volume of 34.23M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.

PFE News

The Motley Fool 5h
Pfizer's Launched and Acquired Drugs Grew 32% in Q3 — and 3 Other Reasons to Buy the Stock Before 2027

Free Article Explore Premium Services Pfizer's Launched and Acquired Drugs Grew 32% in Q3 — and 3 Other Reasons to Buy the Stock Before 2027 Pfizer remains deep...

Pfizer's Launched and Acquired Drugs Grew 32% in Q3 — and 3 Other Reasons to Buy the Stock Before 2027
TipRanks 11h
Pfizer Advances RSV Booster Study in Older Adults

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s NCT07885956 study is officially titled “A PHASE 3, RANDOMIZED, O...

Investing.com 11h
Pfizer near-term support and resistance levels - Investing.com

...

Pfizer near-term support and resistance levels - Investing.com

Analyst ratings

57%

of 30 ratings
Buy
30%
Hold
56.7%
Sell
13.3%

More PFE News

TipRanks 12h
Cboe data shows mixed options sentiment in Pfizer with shares up 1.18%

Cboe data shows mixed options sentiment in Pfizer (PFE), with shares up 32c, or 1.18%, near $27.86. Options volume relatively light with 13k contracts traded an...

Zacks 14h
Investors Heavily Search Pfizer Inc.: Here is What You Need to Know

Pfizer (PFE Quick QuotePFE - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of...

Investors Heavily Search Pfizer Inc.: Here is What You Need to Know
Seeking Alpha 1d
Bipartisan panel says China 'doubling down' on control of pharma supply chain

Bipartisan panel says China 'doubling down' on control of pharma supply chain Nov 19, 2026, 4:09 PM ET Pfizer Inc. (PFE) Stock, NVS Stock, AZN Stock, GSK Stock,...

Bipartisan panel says China 'doubling down' on control of pharma supply chain
TipRanks 1d
Pfizer Advances Phase 3 Trial of Berobenatide for Women With Incontinence and Excess Weight

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s VESPER-SUI study is officially titled “A Phase 3, Randomized, Do...

TipRanks 1d
Pfizer Updates Real-World Migraine Study as Investors Watch Nurtec’s Staying Power

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s CORRELATE-UK study, officially titled CORRELATE-UK: COnsistency...

24/7 Wall St. 1d
Invest $400,000 in These 4 Dividend Stocks Yielding Over 6% for Retirement Income

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Invest $400,000 in These 4 Dividend Stocks Yielding Over 6% for Retirement Income
Zacks 2d
Can New Products and Acquisitions Revive Pfizer's Growth Story?

Pfizer's (PFE Quick QuotePFE - Free Report) business mix has changed significantly over the past few years. During the pandemic, the company became heavil...

Can New Products and Acquisitions Revive Pfizer's Growth Story?

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.